[Microsomal and photochemical oxidation of aflatoxin B1]. 1985

B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk

The UV irradiation (lambda = 362 nm) of aflatoxin B1 (AfB1) dissolved in water resulted in the formation of an oxidized product. The process was not inhibited by ionol, a routine inhibitor of the radical processes. The oxidized product was not found in the system where AfB1 was metabolized by the 3-methylcholanthrene-activated rat liver microsomes. It is suggested that the product is identical with 2,3-dihydrodiol of AfB1.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010782 Photolysis Chemical bond cleavage reactions resulting from absorption of radiant energy. Photodegradation
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D000348 Aflatoxins Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2. Aflatoxin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray

Related Publications

B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
February 1982, Biochimica et biophysica acta,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
July 1998, The Journal of toxicological sciences,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
January 1987, Archives of toxicology,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
December 2006, British poultry science,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
December 1996, Toxicology and applied pharmacology,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
April 1999, Mutation research,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
February 1990, Cancer research,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
March 1977, Molecular pharmacology,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
October 1997, Indian journal of experimental biology,
B L Sergeev, and S P Bogovskiĭ, and T I Veĭdebaum, and R Kh Tanner, and I N Shevchuk
October 1980, Indian journal of experimental biology,
Copied contents to your clipboard!